Literature DB >> 2829606

Degranulated eosinophils, eosinophil granule basic proteins and humoral factors in Nigerians with endomyocardial fibrosis.

G E Urhoghide1, A O Falase.   

Abstract

The frequency of eosinophilia, degranulated eosinophils, and raised serum levels of eosinophil granule basic proteins was determined in ten Nigerians with EMF and fifteen normal controls matched for age and sex, and from the same environment and social background as the patients. Sera from the patients and control subjects were also examined for auto-antibodies, immune complexes, filaria antibodies and immunoglobulins. A mild eosinophilia was observed in four of the patients. The mean direct eosinophil count in the patients (0.407 +/- 0.14 X 10(9)/l) was, however, not significantly different from that of the control subjects (0.399 +/- 0.07 x 10(9)/l). Degranulated eosinophils were absent in the blood and bone marrow aspirates of the patients, and peripheral blood of the controls. It was also found that the mean concentration of eosinophil granule basic proteins (ECP/EPX) in the patients (0.278 +/- 0.1 micrograms/ml) was not significantly different from the mean value for the control subjects (0.371 +/- 0.1 micrograms/ml, P greater than 0.5). Serological studies using Brugia pahangi antigens failed to demonstrate filaria antibodies in the patients and the control subjects. Microfilaria were also absent in their peripheral blood films. Using the indirect immunofluorescent technique, anti-heart antibodies were not demonstrated in the sera of the EMF patients and control subjects. Five (50%) of the patients and four (30.7%) of the normal controls had immune complexes levels far in excess of the upper limit of normal. However, the mean concentration of immune complexes in the patients (16.35%) was not significantly different from the value for control subjects (12.13%, P greater than 0.5).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2829606

Source DB:  PubMed          Journal:  Afr J Med Med Sci        ISSN: 0309-3913


  6 in total

1.  What do we know about endomyocardial fibrosis in children of Africa?

Authors:  Eloi Marijon; Phalla Ou
Journal:  Pediatr Cardiol       Date:  2006-07-06       Impact factor: 1.655

2.  Endomyocardial fibrosis: progression to restricted ventricles and giant atria.

Authors:  Eloi Marijon; Dinesh Jani; Phalla Ou
Journal:  Can J Cardiol       Date:  2006-11       Impact factor: 5.223

3.  Carbimazole-induced lupus.

Authors:  Ihteshamul Haq; Michael D Sosin; Simon Wharton; Anindya Gupta
Journal:  BMJ Case Rep       Date:  2013-02-06

Review 4.  Endomyocardial Fibrosis: an Update After 70 Years.

Authors:  Ana Olga Mocumbi; J Russell Stothard; Paulo Correia-de-Sá; Magdi Yacoub
Journal:  Curr Cardiol Rep       Date:  2019-11-22       Impact factor: 2.931

Review 5.  Endomyocardial fibrosis: still a mystery after 60 years.

Authors:  Gene Bukhman; John Ziegler; Eldryd Parry
Journal:  PLoS Negl Trop Dis       Date:  2008-02-27

Review 6.  Endomyocardial fibrosis: A form of endemic restrictive cardiomyopathy.

Authors:  Ana Olga Mocumbi
Journal:  Glob Cardiol Sci Pract       Date:  2012-07-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.